EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology

Abbas Agaimy iD, Luka Brcic iD, Laurence M Briski, Yin P Hung iD, Michael Michal, Michal Michal, G Petur Nielsen, Robert Stoehr, Andrew E Rosenberg

Genes, Chromosomes and Cancer · 2023-05 · 62 (5) · 256-266

DOI: 10.1002/gcc.23118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 25.12.2022. Verfasst von Abbas Agaimy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany. Hauptthemen laut MEDLINE: Adenoma, Mesothelioma, Peritoneal Neoplasms, Receptors, Steroid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A focal adenomatoid‐microcystic pattern is not uncommon in peritoneal mesothelioma, but tumors composed almost exclusively of this pattern are distinctly rare and have not been well characterized. A small subset of mesotheliomas (mostly in children and young adults) are characterized by gene fusions including EWSR1/FUS::ATF1 , EWSR1::YY1 , and NTRK and ALK rearrangements, and often have epithelioid morphology. Herein, we describe five peritoneal mesothelial neoplasms (identified via molecular screening of seven histologically similar tumors) that are pure adenomatoid/microcystic in morphology and unified by the presence of an NR4A3 fusion. Patients were three males and two females aged 31–70 years (median, 40 years). Three presented with multifocal/diffuse and two with a localized disease. The size of the individual lesions ranged from 1.5 to 8 cm (median, 4.7). The unifocal lesions originated in the small bowel mesentery and the mesosigmoid. Treatment included surgery, either alone (three) or combined with hyperthermic intraperitoneal chemotherapy (two), and neoadjuvant or adjuvant chemotherapy (one case each). At the last follow‐up (6–13 months), all five patients were alive and disease‐free. All tumors were morphologically similar, characterized by extensive sieve‐like microcystic growth with bland‐looking flattened cells lining variably sized microcystic spaces and lacked a conventional epithelioid or sarcomatoid component. Immunohistochemistry confirmed mesothelial differentiation, but most cases showed limited expression of D2‐40 and calretinin. Targeted RNA sequencing revealed an NR4A3 fusion (fusion partners were EWSR1 in three cases and CITED2 and NIPBL in one case each). The nosology and behavior of this morphomolecularly defined novel peritoneal mesothelial neoplasm of uncertain biological potential and its distinction from adenomatoid variants of conventional mesothelioma merit further delineation as more cases become recognized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomaMesotheliomaPeritoneal NeoplasmsReceptors, SteroidFemaleHumansMaleBiomarkers, TumorCell Cycle ProteinsDNA-Binding ProteinsGene FusionMesenteryReceptors, Thyroid HormoneRepressor ProteinsTrans-ActivatorsAdultMiddle AgedAged

Stichwörter der Autor:innen

EWSR1NR4A3adenomatoid tumorgene fusionmicrocysticperitoneal mesothelioma

Substanzen

Biomarkers, TumorCell Cycle ProteinsCITED2 protein, humanDNA-Binding ProteinsNIPBL protein, humanNR4A3 protein, humanReceptors, SteroidReceptors, Thyroid HormoneRepressor ProteinsTrans-Activators

Autor:innen und Institutionen

  • Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.
  • Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Pathology, Charles University, Faculty of Medicine in Plzen, Pilsen, Czech Republic.

ORCID-Profile: Abbas Agaimy, Luka Brcic, Yin P Hung

Zitieren

APA

Agaimy, A., Brcic, L., Briski, L. M., Hung, Y. P., Michal, M., Michal, M., Nielsen, G. P., Stoehr, R., & Rosenberg, A. E. (2023). NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology. Genes, Chromosomes and Cancer, 62(5), 256-266. https://doi.org/10.1002/gcc.23118

Vancouver

Agaimy A, Brcic L, Briski LM, Hung YP, Michal M, Michal M, et al. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology. Genes, Chromosomes and Cancer. 2023;62(5):256-266. doi:10.1002/gcc.23118

BibTeX
@article{Agaimy2023,
  author = {Agaimy, Abbas and Brcic, Luka and Briski, Laurence M and Hung, Yin P and Michal, Michael and Michal, Michal and Nielsen, G Petur and Stoehr, Robert and Rosenberg, Andrew E},
  title = {NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  volume = {62},
  number = {5},
  pages = {256--266},
  doi = {10.1002/gcc.23118}
}
Kostenlos starten →